title: A needle in a haystack: Identifying biomarkers to personalize systemic therapy in patients with hepatocellular carcinoma.
authors.forename: Henning
authors.initials: H
authors.lastname: Wege
authors.forename: Tim H
authors.initials: TH
authors.lastname: Brümmendorf
authors.forename: Carlo
authors.initials: C
authors.lastname: Gambacorti-Passerini
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology*; D005260:Female; D051518:Fibroblast Growth Factor 3 / Q000235:genetics*; D051519:Fibroblast Growth Factor 4 / Q000235:genetics*; D005784:Gene Amplification / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000453:epidemiology*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; C496444:FGF3 protein, human; C496445:FGF4 protein, human; D051518:Fibroblast Growth Factor 3; D051519:Fibroblast Growth Factor 4; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib